{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:45:39Z","timestamp":1790286339231,"version":"4.1.0"},"reference-count":293,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>This narrative review of Alzheimer\u2019s disease (AD) history, therapy and prevention shows that its conceptualization has changed three times over 100 years. First, AD was a normative creation by Kraepelin in 1910 of a rare presenile dementia characterized by specific histological features. Second, during the 1970s, American neurologists, driven by sociological changes, merged presenile and senile dementias into an Alzheimer-type dementia with the universally accepted clinicopathological diagnostic criteria of McKhann. By the end of the 20th century, AD was divided into early-onset genetic (1%) and late-onset sporadic (99%) forms. In the 21st century, AD was redefined as a biological entity, using biological and neuroimaging markers of amyloid, tau and neurodegeneration, to better address research and clinical trials. This new nosology has been widely criticized, given the absence of curative therapy, the evidence of mixed pathology in most cases and the decline in the dementia\/AD incidence in high-income countries. However, there are currently many drugs against AD in the pipeline; prevention appears as medical and social therapy. In summary, the ancient concept of age-related dementia has evolved into AD normative disorders over 100 years. Nowadays, AD requires a conceptual reassessment, although its medical paradigm remains. Awaiting pharmacological breakthroughs, dementia prevention seems the best practical approach.<\/jats:p>","DOI":"10.3390\/jcm14217752","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:30:27Z","timestamp":1762198227000},"page":"7752","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alzheimer Syndrome or Age-Related Dementia\u2014History, Therapy and Prevention"],"prefix":"10.3390","volume":"14","author":[{"given":"F\u00e9lix","family":"Bermejo-Pareja","sequence":"first","affiliation":[{"name":"Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, 28029 Madrid, Spain"},{"name":"Medical School, Complutense University of Madrid (UCM), 28040 Madrid, Spain"},{"name":"Imas 12, University Hospital \u201c12 de Octubre\u201d, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9806-7083","authenticated-orcid":false,"given":"Teodoro","family":"del Ser","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Centre Reina Sofia\u2014CIEN Foundation, Institute of Health Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/jmp\/jhu035","article-title":"Second rebuttal of health","volume":"39","author":"Boorse","year":"2014","journal-title":"J. Med. Philosophy"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00993985","article-title":"On the relevance and importance of the notion of disease","volume":"14","author":"Nordenfelt","year":"1993","journal-title":"Theoretical Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/jmp\/jhu037","article-title":"Naturalism about health and disease: Adding nuance for progress","volume":"39","author":"Kingma","year":"2014","journal-title":"J. Med. Philosophy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2753.2010.01393.x","article-title":"The concept of health: Beyond normativism and naturalism","volume":"16","author":"Hamilton","year":"2010","journal-title":"J. Eval. Clin. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11019-021-10058-9","article-title":"Health and disease as practical concepts: Exploring function in context-specific definitions","volume":"25","author":"Schermer","year":"2022","journal-title":"Med. Health Care Philos."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Xiao, X., Song, H., Sang, T., Wu, Z., Xie, Y., and Yang, Q. (2021). Analysis of Real-World Implementation of the Biopsychosocial Approach to Healthcare: Evidence From a Combination of Qualitative and Quantitative Methods. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.725596"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Schleidgen, S., Fernau, S., Fleischer, H., Schickhardt, C., O\u00dfa, A.K., and Winkler, E.C. (2017). Applying systems biology to biomedical research and health care: A pr\u00e9cising definition of system- medicine. BMC Health Ser. Res., 17.","DOI":"10.1186\/s12913-017-2688-z"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kraepelin, E. (1910). Psychiatrie: Ein Lehrbuch Fuer Studierende Und Aerzte, Verlag von Johann Ambrosius Barth. (Description in English in: \u201cSchorer, C.E. Historical essay: Kraepelin\u2019s description of Alzheimer\u2019s disease. Int. J. Aging Hum. Dev.\u00a01985, 21, 235\u2013238. https:\/\/doi.org\/10.2190\/gnq1-gdux-eptl-0f2l\u201d).","DOI":"10.2190\/GNQ1-GDUX-EPTL-0F2L"},{"key":"#cr-split#-ref_9.1","unstructured":"Alzheimer, A. (1907). Ueber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift F\u00fcr Psychiatrie und Psychisch-gerichtliche Medizin, Forgotten Books. (English version in: Jarvik, L."},{"key":"#cr-split#-ref_9.2","unstructured":"Greenson, H. About a peculiar disease of the cerebral cortex. By Alois Alzheimer, 1907. Alzheimer Dis. Assoc. Disord.\u00a01987, 1, 3-8. PMID: 3331112)."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02866241","article-title":"\u00dcber eigenartige Krankheitsf\u00e4lle des sp\u00e4teren Alters","volume":"4","author":"Alzheimer","year":"1911","journal-title":"Z. Ges. Neurol. Psychiatr."},{"key":"ref_11","unstructured":"Bermejo-Pareja, F. (2025). The changing nosology of Alzheimer disease over more than 100 years. A historical overview. Neurosc. History, in press."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ballenger, J.F. (2006). Self, Senility, and Alzheimer\u2019s Disease in Modern America: A History, The John Hopkins University Press.","DOI":"10.1353\/book.3237"},{"key":"ref_13","unstructured":"Terry, R.D., Katzman, R., Bick, K.L., and Sisodia, S.S. (1999). The early story of Alzheimer\u2019s disease. Alzheimer Disease, Lippincott W&W."},{"key":"ref_14","unstructured":"Katzman, R., Terry, R.D., and Bick, K.L. (1978). Recommendation of nosology, epidemiology, and pathophysiology commissions of the Workshop-Conference on Alzheimer\u2019s dementia and related disorders. Alzheimer\u2019s Disease: Senile Dementia and Related Disorders, Raven Press."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bermejo-Pareja, F., and Del Ser, T. (2024). Controversial past, splendid present, unpredictable future: A brief review of Alzheimer disease history. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020536"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Herrup, K. (2021). How not to Study a Disease: The Story of Alzheimer\u2019s Disease. The MIT Press.","DOI":"10.7551\/mitpress\/12423.001.0001"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","article-title":"Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: Combined data from 13 community-based or population-based autopsy cohorts","volume":"144","author":"Nelson","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/alz.12379","article-title":"Bayes analysis supports null hypothesis of anti-amyloid beta therapy in Alzheimer\u2019s disease","volume":"17","author":"Richard","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Behl, C. (2023). Alzheimer\u2019s Disease Research: What Has Guided Research So Far and Why It Is High Time for a Paradigm Shift, Springer Nature.","DOI":"10.1007\/978-3-031-31570-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1212\/WNL.0000000000010022","article-title":"Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium","volume":"95","author":"Wolters","year":"2020","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11019-020-09963-2","article-title":"An analytic framework for conceptualisations of disease: Nine structuring questions and how some conceptualisations of Alzheimer\u2019s disease can lead to \u2018diseasisation\u2019","volume":"23","author":"Zeiler","year":"2020","journal-title":"Med. Health Care Philos."},{"key":"ref_27","unstructured":"George, D.R., and Whitehouse, P.J. (2021). American Dementia Brain Health in an Unhealthy Society, Johns Hopkins University Press."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","article-title":"Reimagining Alzheimer\u2019s disease\u2014An age-based hypothesis","volume":"30","author":"Herrup","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lock, M. (2013). The Alzheimer Conundrum: Entanglements of Dementia and Aging, Princeton University Press.","DOI":"10.23943\/princeton\/9780691149783.001.0001"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Liu, R.M. (2022). Aging, cellular senescence, and Alzheimer\u2019s disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23041989"},{"key":"ref_31","unstructured":"Sain-Jean, O., and Favereau, E. (2018). Alzheimer, le Gran Leurre, Michalon Edit."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Fiorini, N., Canese, K., Starchenko, G., Kireev, E., Kim, W., Miller, V., Osipov, M., Kholodov, M., Ismagilov, R., and Mohan, S. (2018). Best match: New relevance search for PubMed. PLoS Biol., 16.","DOI":"10.1093\/database\/bay094"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"328a","DOI":"10.1126\/science.274.5286.328a","article-title":"Alzheimer\u2019s original patient","volume":"274","author":"Amaducci","year":"1996","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"s11013","DOI":"10.1007\/s11013-019-09622-z","article-title":"What is \u2018Alzheimer\u2019s Disease\u2019? The \u2018Auguste D\u2019 Case. Re-opened","volume":"43","author":"Keohane","year":"2019","journal-title":"Cult. Med. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jalz.2014.06.005","article-title":"A presenilin 1 mutation in the first case of Alzheimer\u2019s disease: Revisited","volume":"10","author":"Rupp","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00005072-199311000-00012","article-title":"Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa","volume":"52","author":"Hansen","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.36.11.1497","article-title":"Origin of the distinction on between Alzheimer\u2019s disease and senile dementia","volume":"35","author":"Amaducci","year":"1986","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jhmas\/42.3.327","article-title":"The history of Alzheimer\u2019s disease: Three debates","volume":"42","author":"Beach","year":"1987","journal-title":"J. Hist. Med. Allied Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Piller, C. (2025). Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer\u2019s, Simond & Schuster.","DOI":"10.53053\/SNYL7327"},{"key":"ref_40","first-page":"193","article-title":"Zur Kenntnis der Hirnveranderungen bei der normalen Altersinvolution","volume":"38","author":"Gellerstedt","year":"1933","journal-title":"Upsala Lakar Forh."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02866372","article-title":"Ein weiterer Beitrag zur Klinik und Pathologie der presbyophrenen Demenz","volume":"12","author":"Fischer","year":"1912","journal-title":"Z. Ges Neurol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archneurpsyc.1929.02210220076003","article-title":"Alzheimer\u2019s disease: A contribution to its etiology and classification","volume":"21","author":"Malamud","year":"1929","journal-title":"Arch. Neurol. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/ajp.88.2.269","article-title":"Alzheimer\u2019s disease: Its occurrence on the basis of a variety of etiologic factors","volume":"11","author":"Lowenberg","year":"1931","journal-title":"Am. J. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jnnp.3.3.211","article-title":"Alzheimer\u2019s disease: A report of six cases","volume":"3","author":"McMenemey","year":"1940","journal-title":"J. Neurol. Psychiatry"},{"key":"ref_45","first-page":"213","article-title":"Syndroom van Alzheimer","volume":"54","author":"Schenk","year":"1954","journal-title":"Acta Neurol. Psychiatr. Belg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1192\/bjp.94.395.225","article-title":"The identity of Alzheimer\u2019s disease and senile dementia and their relationship to senility","volume":"94","author":"Newton","year":"1948","journal-title":"J. Ment. Sci."},{"key":"ref_47","first-page":"297","article-title":"Uber klinisch und histologisch eigenartige psychische Erkrankungen des sp\u00e4teren Lebensalters. Histologische und histopathologische","volume":"3","author":"Perusini","year":"1910","journal-title":"Arbeiten"},{"key":"ref_48","first-page":"208","article-title":"Uber miliaere Sklerose der Hirnrinde bei seniler Atrophie","volume":"17","author":"Redlich","year":"1898","journal-title":"Jahr. Psychiatr. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000211873","article-title":"Miliare Nekrosen mit drusigenWucherungen der Neurofibrillen, eine regelmassige Veranderung der Hirnrinde bei seniler Demenz","volume":"22","author":"Fischer","year":"1907","journal-title":"Monatsschr. Psychiat. Neurol."},{"key":"ref_50","first-page":"5468","article-title":"A study of the neurofibrils in dementia paralytica, dementia senilis, chronic alcoholism cerebral lues and microcephalic idiocy","volume":"63","author":"Fuller","year":"1907","journal-title":"Am. J. Insan"},{"key":"ref_51","first-page":"193","article-title":"Sul valore nosografico di alcuni reperti istopatologici caratteristiche per la senilita","volume":"4","author":"Perusini","year":"1911","journal-title":"Riv. Ital. Neirroputol Psichiutr Eiettroter."},{"key":"ref_52","first-page":"267","article-title":"Histologische Studien uber die Senile Demenz","volume":"4","author":"Simchowicz","year":"1911","journal-title":"Histol. Histoputhol Arb. Grosshirnr."},{"key":"ref_53","first-page":"1","article-title":"Zur Kenntnis der Alzheimerschen Krankheit (pr\u00e4senilen Demenz mit Herdsymptomen)","volume":"18","author":"Bielschowsky","year":"1911","journal-title":"J. Psychol. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005053-191207000-00002","article-title":"Alzheimer\u2019s disease (senium praecox): The report of a case and review of published cases","volume":"39","author":"Fuller","year":"1912","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005053-191306000-00001","article-title":"A case of Alzheimer\u2019s disease with unusual neurological disturbances","volume":"40","author":"Barrett","year":"1913","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_56","first-page":"169","article-title":"The clinical and anatomic features of Alzheimer\u2019s disease","volume":"9","author":"Lambert","year":"1916","journal-title":"Psychiat. Bull. N. Y. State Hosp."},{"key":"ref_57","first-page":"220","article-title":"Sur la signification de plaques s\u00e9niles et sur la formule s\u00e9nil de l\u2019\u00e9corce c\u00e9r\u00e9brale","volume":"31","author":"Simchowicz","year":"1924","journal-title":"Rev. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1192\/bjp.76.315.646","article-title":"Alzheimer\u2019s Disease","volume":"76","author":"Henderson","year":"1930","journal-title":"J. Ment. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1176\/ajp.91.3.485","article-title":"Alzheimer\u2019s Disease: A Clinicopathologic Study of Five Cases","volume":"91","author":"Rothschild","year":"1934","journal-title":"Am. J. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archneurpsyc.1936.02260080065004","article-title":"Clinic-pathologic study of Alzheimer\u2019s disease: Relationship to senile condition","volume":"36","author":"Rothschild","year":"1936","journal-title":"Arch. Neurol. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1176\/ajp.93.1.39","article-title":"Alzheimer\u2019s disease\u2014The so-called juvenile type","volume":"93","author":"Jervis","year":"1936","journal-title":"Am. J. Psychiatry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1176\/ajp.93.4.757","article-title":"Pathologic changes in senile psychoses and their psychobiologic significance","volume":"93","author":"Rothschild","year":"1937","journal-title":"Am. J. Psychiatry"},{"key":"ref_63","first-page":"361","article-title":"A case of Alzheimer\u2019s disease with neuropathological findings","volume":"35","author":"Hannah","year":"1936","journal-title":"Can. Med. Assoc. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005053-195308000-00001","article-title":"Alzheimer\u2019s disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis","volume":"118","author":"Goodman","year":"1953","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1192\/bjp.101.423.281","article-title":"The natural history of mental disorder in old age","volume":"101","author":"Roth","year":"1955","journal-title":"J. Ment. Sci."},{"key":"ref_66","unstructured":"Corsellis, J.A.N. (1962). Mental Illness and the Aging Brain: The Distribution of Pathological Changes in a Mental Hospital Population, University Press."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/197192b0","article-title":"Paired helical filaments in electron microscopy of Alzheimer\u2019s disease","volume":"197","author":"Kidd","year":"1963","journal-title":"Nature"},{"key":"ref_68","first-page":"1","article-title":"Senile dementia. A clinical, sociomedical and genetic study","volume":"39","author":"Larsson","year":"1963","journal-title":"Acta Psychiat. Scand."},{"key":"ref_69","first-page":"269","article-title":"Ultrastructural studies in Alzheimer\u2019s presenile dementia","volume":"44","author":"Terry","year":"1964","journal-title":"Am. J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","article-title":"The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects","volume":"114","author":"Blessed","year":"1968","journal-title":"Br. J. Psychiatry"},{"key":"ref_71","first-page":"335","article-title":"Senile cerebral disease. A critical survey of traditional concepts based upon observations with newer techniques","volume":"8","author":"Margolis","year":"1959","journal-title":"Lab. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1192\/bjp.115.520.267","article-title":"Clinical heterogeneity in senile dementia","volume":"115","author":"McDonald","year":"1969","journal-title":"Br. J. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2307\/3350070","article-title":"From senility to Alzheimer\u2019s disease: The rise of the Alzheimer\u2019s disease movement","volume":"67","author":"Fox","year":"1989","journal-title":"Milbank Q."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/gte.1999.3.13","article-title":"Defining dementia: Social and historical background of Alzheimer disease","volume":"3","author":"Fox","year":"1999","journal-title":"Genet. Test."},{"key":"ref_75","unstructured":"Karlawish, J. (2021). The Problem of Alzheimer\u2019s Disease. How Science Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do about It, St. Martin\u2019s Publishing Group."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1976.00500040001001","article-title":"Editorial: The prevalence and malignancy of Alzheimer disease. A major killer","volume":"33","author":"Katzman","year":"1976","journal-title":"Arch. Neurol."},{"key":"ref_77","unstructured":"Kuhn, T.S. (1970). The Structure of Scientific Revolutions, University of Chicago."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/01616412.1993.11740127","article-title":"Can disturbed brain microcirculation cause Alzheimer\u2019s disease?","volume":"15","author":"Mussivand","year":"1993","journal-title":"Neurol. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-191281","article-title":"Evolution of the research literature and the scientific community of Alzheimer\u2019s disease from 1983-2017, A 35-year survey","volume":"75","author":"Robert","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neurol.2023.12.006","article-title":"Lessons from genetic studies in Alzheimer disease","volume":"180","author":"Nicolas","year":"2024","journal-title":"Rev. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: Advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Das","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","article-title":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","volume":"34","author":"Yang","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1469-1809.1999.6340301.x","article-title":"Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a \u2018thrifty\u2019 allele?","volume":"63","author":"Corbo","year":"1999","journal-title":"Ann. Hum. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tins.2014.03.001","article-title":"Exercise, APOE genotype, and the evolution of the human lifespan","volume":"37","author":"Raichlen","year":"2014","journal-title":"Trends Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer\u2019s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Soscia, S.J., Kirby, J.E., Washicosky, K.J., Tucker, S.M., Ingelsson, M., Hyman, B., Burton, M.A., Goldstein, L.E., Duong, S., and Tanzi, R.E. (2010). The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009505"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"340ra72","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer\u2019s Disease-Associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/nipt-2023-0011","article-title":"The elusive role of herpesviruses in Alzheimer\u2019s disease: Current evidence and future directions","volume":"2","author":"Piotrowski","year":"2023","journal-title":"Neuroimmune Pharm. Ther."},{"key":"ref_93","unstructured":"Whitehouse, P.J., and George, D. (2008). The Myth of Alzheimer\u2019 Disease, St Martin\u2019s Griffin."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1126\/science.1857970","article-title":"Deposits of amyloid beta protein in the central nervous system of transgenic mice","volume":"253","author":"Wirak","year":"1991","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Koh","year":"2006","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.add9993","article-title":"Blots on a field?","volume":"377","author":"Piller","year":"2022","journal-title":"Science"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1126\/science.ade2733","article-title":"Editor\u2019s note","volume":"377","author":"Appenzeller","year":"2022","journal-title":"Science"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1126\/science.adt3535","article-title":"Picture imperfect","volume":"385","author":"Piller","year":"2024","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1126\/science.adt5694","article-title":"Firm misled investors on Alzheimer\u2019s drug, SEC charges","volume":"386","author":"Piller","year":"2024","journal-title":"Science"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/brain\/awz142","article-title":"Persistent neuropathological effects 14 years following amyloid-\u03b2 immunization in Alzheimer\u2019s disease","volume":"142","author":"Nicoll","year":"2019","journal-title":"Brain"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"149018","DOI":"10.1016\/j.brainres.2024.149018","article-title":"Immunotherapeutic approaches for Alzheimer\u2019s disease: Exploring active and passive vaccine progress","volume":"1840","author":"Bhadane","year":"2024","journal-title":"Brain Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat. Neurosc."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Fedele, E. (2023). Anti-amyloid therapies for Alzheimer\u2019s disease and the Amyloid Cascade Hypothesis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914499"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1093\/brain\/awad159","article-title":"The amyloid cascade hypothesis: An updated critical review","volume":"146","author":"Robakis","year":"2023","journal-title":"Brain"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Christopher","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0197-4580(00)00211-6","article-title":"Copernicus revisited: Amyloid beta in Alzheimer\u2019s disease","volume":"22","author":"Joseph","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"ref_108","unstructured":"Begley, S. (2025, February 28). The Maddening Saga of How Alzheimer\u2019s \u2018Cabal\u2019 Thwarted Progress Toward a Cure for Decades. STAT [Internet]. Available online: https:\/\/www.statnews.com\/2019\/06\/25\/alzheimers-cabal-thwarted-progress-toward-cure\/."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer\u2019s disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-12679-1_1","article-title":"Neuroanatomy and pathology of sporadic Alzheimer\u2019s disease","volume":"Volume 215","author":"Braak","year":"2015","journal-title":"Advances in Anatomy, Embryology and Cell Biology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","article-title":"Alzheimer\u2019s disease-do tauists and baptists finally shake hands?","volume":"25","author":"Mudher","year":"2002","journal-title":"Trends Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e23254","DOI":"10.1002\/ajp.23254","article-title":"Studies of aging nonhuman primates illuminate the etiology of early-stage Alzheimer\u2019s-like neuropathology: An evolutionary perspective","volume":"83","author":"Arnsten","year":"2021","journal-title":"Am. J. Primatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: Understanding the Alzheimer\u2019s disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_116","first-page":"1","article-title":"Neuropathology of the Alzheimer\u2019s continuum: An update","volume":"1","author":"Jellinger","year":"2020","journal-title":"Free Neuropathol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1504327","article-title":"Incidence of dementia over three decades in the Framingham Heart Study","volume":"374","author":"Satizabal","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/brain\/awu035","article-title":"Compensatory mechanisms in higher-educated subjects with Alzheimer\u2019s disease: A study of 20 years of cognitive decline","volume":"137","author":"Amieva","year":"2014","journal-title":"Brain"},{"key":"ref_119","unstructured":"Bermejo-Pareja, F. (2018). Alzheimer: Prevention from Childhood, Lamberth Academic Publishing."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: Revising the NINCDS\u2013ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.revmed.2007.11.018","article-title":"Pour une nouvelle conception de la maladie d\u2019Alzheimer","volume":"29","author":"Dubois","year":"2008","journal-title":"Rev. Med. Interne"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer\u2019s Association. Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer Disease as a clinical-biological construct\u2014An International Working Group Recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1474-4422(15)00323-3","article-title":"Transition rates between amyloid and neurodegeneration biomarker states and to dementia: A population-based, longitudinal cohort study","volume":"15","author":"Jack","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcp.2013.11.009","article-title":"Perspective on future role of biological markers in clinical therapy trials of Alzheimer\u2019s disease: A long-range point of view beyond 2020","volume":"88","author":"Hampel","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jmp\/jhad009","article-title":"Preclinical disease or risk factor? Alzheimer\u2019s disease as a case study of changing conceptualizations of disease","volume":"48","author":"Schermer","year":"2023","journal-title":"J. Med. Philos."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1474-4422(11)70055-2","article-title":"New lexicon and criteria for the diagnosis of Alzheimer\u2019s disease","volume":"10","author":"Giaccone","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000321121","article-title":"Lack of accuracy for the proposed \u2018Dubois Criteria\u2019 in Alzheimer\u2019s disease: A validation study from the Swedish Brain Power Initiative","volume":"30","author":"Oksengard","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_132","unstructured":"Kovacs, G.G., and Alafuzoff, I. (2018). Techniques in neuropathology. Handbook of Clinical Neurology, Elsevier B.V."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/S2666-7568(23)00019-3","article-title":"The prevalence, correlation, and co-occurrence of neuropathology in old age: Harmonisation of 12 measures across six community-based autopsy studies of dementia","volume":"4","author":"Nichols","year":"2023","journal-title":"Lancet Healthy Longev."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/WCO.0000000000000910","article-title":"What have we learned from cognition in the oldest-old","volume":"34","author":"Kawas","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","article-title":"Age, neuropathology, and dementia","volume":"360","author":"Savva","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"King, A., Bodi, I., and Troakes, C. (2020). The Neuropathological diagnosis of Alzheimer\u2019s disease\u2014The challenges of pathological mimics and concomitant pathology. Brain Sci., 10.","DOI":"10.3390\/brainsci10080479"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awaa438","article-title":"The development and convergence of co-pathologies in Alzheimer\u2019s disease","volume":"144","author":"Robinson","year":"2021","journal-title":"Brain"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/alz.12516","article-title":"Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population","volume":"18","author":"Godrich","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1212\/WNL.0000000000013252","article-title":"Neuropathologic correlates of human cortical proteins in Alzheimer disease and related dementias","volume":"98","author":"Yu","year":"2022","journal-title":"Neurology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.123.19943","article-title":"Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia","volume":"81","author":"Hainsworth","year":"2024","journal-title":"Hypertension"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Burgue\u00f1o-Garc\u00eda, I., L\u00f3pez-Mart\u00ednez, M.J., Uceda-Heras, A., Garc\u00eda-Carracedo, L., Zea-Sevilla, M.A., Rodrigo-Lara, H., Rego-Garc\u00eda, I., Saiz-A\u00faz, L., Ruiz-Valderrey, P., and L\u00f3pez-Gonz\u00e1lez, F.J. (2024). Neuropathological heterogeneity of dementia due to combined pathology in aged patients: Clinicopathological findings in the Vallecas Alzheimer\u2019s Reina Sof\u00eda Cohort. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226755"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e70539","DOI":"10.1002\/alz.70539","article-title":"Identifying dementia neuropathology using low-burden clinical data","volume":"21","author":"Ren","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.publhealth.25.101802.122951","article-title":"Can dementia be prevented? Brain aging in a population-based context","volume":"25","author":"Haan","year":"2004","journal-title":"Annu. Rev. Public. Health"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0447.2011.01754.x","article-title":"Incidence and lifetime risk of dementia and Alzheimer\u2019s disease in a Southern European population","volume":"124","author":"Lobo","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jalz.2010.11.002","article-title":"Trends in the incidence and prevalence of Alzheimer\u2019s disease, dementia, and cognitive impairment in the United States","volume":"7","author":"Rocca","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/WNL.0b013e3182553be6","article-title":"Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study","volume":"78","author":"Schrijvers","year":"2012","journal-title":"Neurology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1038\/ncomms11398","article-title":"A two decades dementia incidence comparison from the Cognitive Function and Ageing Studies I and II","volume":"7","author":"Matthews","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jalz.2015.11.001","article-title":"Trends in dementia incidence: Evolution over a 10-year period in France","volume":"12","author":"Grasset","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_150","first-page":"j2856","article-title":"Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040, modelling study","volume":"358","author":"Bandosz","year":"2017","journal-title":"BMJ"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2017.1964","article-title":"Trends in dementia incidence in a birth cohort analysis of the Einstein Aging Study","volume":"74","author":"Derby","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-170300","article-title":"Secular trends in the incidence of dementia in a multi-ethnic community","volume":"60","author":"Noble","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneurol.2017.63","article-title":"The changing prevalence and incidence of dementia over time\u2014Current evidence","volume":"13","author":"Wu","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/jgs.16027","article-title":"Incidence of dementia and Alzheimer disease over time: A meta-analysis","volume":"67","author":"Gao","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2147\/CLEP.S178955","article-title":"Thirty-year trends in dementia: A nationwide population study of Swedish inpatient records","volume":"10","author":"Seblova","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/gerona\/gly236","article-title":"Declining incident dementia rates across four population-based birth cohorts","volume":"74","author":"Sullivan","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/jgs.17345","article-title":"Impact of dementia: Health disparities, population trends, care interventions, and economic costs","volume":"69","author":"Aranda","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Contador, I., Buch-Vicente, B., Del Ser, T., Llamas-Velasco, S., Villarejo-Galende, A., Benito-Le\u00f3n, J., and Bermejo-Pareja, F. (2024). Charting Alzheimer\u2019s disease and dementia: Epidemiological insights, risk factors and prevention pathways. J. Clin. Med., 13.","DOI":"10.3390\/jcm13144100"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e12190","DOI":"10.1002\/trc2.12190","article-title":"Preventing Alzheimer\u2019s disease within reach by 2025, Targeted-risk-AD-prevention (TRAP) strategy","volume":"7","author":"Vitali","year":"2021","journal-title":"Transl. Res. Clin. Interv."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/08982643211029716","article-title":"Trends in dementia prevalence, incidence, and mortality in the United States (2000\u20132016)","volume":"34","author":"Farina","year":"2022","journal-title":"J. Aging Health"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41562-023-01585-x","article-title":"Identifying modifiable factors and their joint effect on dementia risk in the UK Biobank","volume":"7","author":"Zhang","year":"2023","journal-title":"Nat. Hum. Behav."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e2219672","DOI":"10.1001\/jamanetworkopen.2022.19672","article-title":"Variation in population attributable fraction of dementia associated with potentially modifiable risk factors by race and ethnicity in the US","volume":"5","author":"Lee","year":"2022","journal-title":"JAMA Netw. Open."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/aje\/kwad138","article-title":"Have We Been Underestimating Modifiable Dementia Risk? An alternative approach for calculating the combined population attributable fraction for modifiable dementia risk factors","volume":"192","author":"Welberry","year":"2023","journal-title":"Am. J. Epidemiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2666-7568(24)00061-8","article-title":"Population attributable fractions of modifiable risk factors for dementia: A systematic review and meta-analysis","volume":"5","author":"Stephan","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-2012-121459","article-title":"A modest proposal for a longitudinal study of dementia prevention (with apologies to Jonathan Swift, 1729)","volume":"33","author":"Friedland","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2017.09.006","article-title":"Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial","volume":"14","author":"Rosenberg","year":"2018","journal-title":"Alzheimer\u2018s Dement."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jamainternmed.2023.8522","article-title":"Dementia prevention and treatment: A narrative review","volume":"184","author":"Reuben","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"ref_168","first-page":"115","article-title":"Vers une pharmacologie de l\u2019activit\u00e9 int\u00e9grative du cerveau. Tentative du concept nootrope en psychopharmacologie","volume":"25","author":"Giurgea","year":"1972","journal-title":"Actual Pharmacol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"894","DOI":"10.7326\/0003-4819-100-6-894","article-title":"Ergoloid mesylates for senile dementias: Unanswered questions","volume":"100","author":"Hollister","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0197-4580(86)90007-2","article-title":"Piracetam combined with lecithin in the treatment of Alzheimer\u2019s disease","volume":"7","author":"Growdon","year":"1986","journal-title":"Neurobiol. Aging"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM198611133152001","article-title":"Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type","volume":"315","author":"Summers","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1532-5415.1989.tb05682.x","article-title":"The safety and lack of efficacy of vinpocetine in Alzheimer\u2019s disease","volume":"37","author":"Thal","year":"1989","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02246209","article-title":"Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: A double-blind, placebo-controlled, clinical and EEG\/ERP mapping study","volume":"117","author":"Saletu","year":"1995","journal-title":"Psychopharmacology"},{"key":"ref_174","first-page":"439","article-title":"Clinical findings with nimodipine in dementia: Test of the calcium hypothesis","volume":"46","author":"Fritze","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"ref_175","first-page":"293","article-title":"The efficacy and safety of donepezil in patients with Alzheimer\u2019s disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group","volume":"7","author":"Rogers","year":"1996","journal-title":"Dementia"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.318.7184.633","article-title":"Efficacy and safety of rivastigmine in patients with Alzheimer\u2019s disease: International randomised controlled trial","volume":"318","author":"Anand","year":"1999","journal-title":"BMJ"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0","article-title":"Memantine in severe dementia: Results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine)","volume":"14","author":"Winblad","year":"1999","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/WNL.54.12.2261","article-title":"Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group","volume":"54","author":"Raskind","year":"2000","journal-title":"Neurology"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/156720505774932287","article-title":"A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer\u2019s type","volume":"2","author":"Schneider","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2008.683","article-title":"Ginkgo Evaluation of Memory (GEM) Study Investigators. Ginkgo biloba for prevention of dementia: A randomized controlled trial","volume":"300","author":"DeKosky","year":"2008","journal-title":"JAMA"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Bapineuzumab 301 and 302 Clinical Trial Investigators. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab and bapineuzumab for Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Aisen","year":"2022","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: Current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"102203","DOI":"10.1016\/j.arr.2024.102203","article-title":"Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and network meta-analysis","volume":"94","author":"Terao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000316119","article-title":"Nonpharmacological therapies in Alzheimer\u2019s disease: A systematic review of efficacy","volume":"30","author":"Reisberg","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-201554","article-title":"Benefits in Alzheimer\u2019s disease of sensory and multisensory stimulation","volume":"82","author":"Yang","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3945\/an.116.012138","article-title":"Mediterranean diet, cognitive function, and dementia: A systematic review of the evidence","volume":"7","author":"Petersson","year":"2016","journal-title":"Adv. Nutr."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nyas.14864","article-title":"The promise of music therapy for Alzheimer\u2019s disease: A review","volume":"1516","author":"Matziorinis","year":"2022","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.3233\/JAD-240719","article-title":"The therapeutic potential of yoga for Alzheimer\u2019s Disease: A Critical Review","volume":"101","author":"Brown","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"102312","DOI":"10.1016\/j.arr.2024.102312","article-title":"Effectiveness of Cognitive Stimulation Therapy (CST) for mild to moderate dementia: A systematic literature review and meta-analysis of randomised control trials using the original CST protocol","volume":"97","author":"Desai","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2698811251340901","DOI":"10.1177\/02698811251340901","article-title":"Comparative efficacy, tolerability, and acceptability of aducanumab, lecanemab, and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and network meta-analysis","volume":"19","author":"Terao","year":"2025","journal-title":"J. Psychopharmacol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"e70498","DOI":"10.1002\/alz.70498","article-title":"Cognitive outcomes of deep brain stimulation depend on age and hippocampal connectivity in Parkinson\u2019s and Alzheimer\u2019s disease","volume":"21","author":"Howard","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11481-019-09849-y","article-title":"Next generation precision medicine: CRISPR-mediated genome editing for the treatment of neurodegenerative disorders","volume":"14","author":"Raikwar","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer\u2019s disease: Current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/bs.pmbts.2019.10.001","article-title":"Combination therapy for Alzheimer\u2019s disease and related dementias","volume":"168","author":"Bednar","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13287-024-03737-w","article-title":"Promoting Alzheimer\u2019s disease research and therapy with stem cell technology","volume":"15","author":"Cao","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e70293","DOI":"10.1002\/alz.70293","article-title":"TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer\u2019s disease","volume":"21","author":"Salloway","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jama.2025.14180","article-title":"Treating Alzheimer disease with antiamyloid therapies-The real-world experience grows","volume":"334","author":"Rubin","year":"2025","journal-title":"JAMA"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"102348","DOI":"10.1016\/j.arr.2024.102348","article-title":"Donanemab, another anti-Alzheimer\u2019s drug with risk and uncertain benefit","volume":"99","author":"Alavi","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/13872877251361044","article-title":"Efficacy and APOE \u03b54-stratified risk of donanemab in Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized clinical trials","volume":"107","author":"Virgilio","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/03007995.2025.2458530","article-title":"Communicating scientific evidence: Drugs for Alzheimer\u2019s disease as a case study","volume":"41","author":"Kepp","year":"2025","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/bcp.70021","article-title":"Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer\u2019s disease: The pharmacovigilance perspective","volume":"91","author":"Bobbins","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1212\/WNL.0000000000207505","article-title":"Lecanemab: Looking before we leap","volume":"101","author":"Burke","year":"2023","journal-title":"Neurology"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10654-025-01220-1","article-title":"Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer\u2019s disease to individuals with mild cognitive impairment or early Alzheimer\u2019s disease in the general population","volume":"40","author":"Claus","year":"2025","journal-title":"Eur. J. Epidemiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/13872877251331243","article-title":"Donanemab eligibility in early Alzheimer\u2019s disease: A real-world study","volume":"105","author":"Urso","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-025-09335-x","article-title":"Lithium deficiency and the onset of Alzheimer\u2019s disease","volume":"645","author":"Aron","year":"2025","journal-title":"Nature"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/JCMA.0000000000001252","article-title":"A 2025 update on treatment strategies for the Alzheimer\u2019s disease spectrum","volume":"88","author":"Wu","year":"2025","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_210","first-page":"49","article-title":"A Critique of the 2018 National Institute on Aging\u2019s. Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"9","author":"Garret","year":"2018","journal-title":"Curr. Neurobiol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13195-019-0543-7","article-title":"Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes","volume":"11","author":"Carandini","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"n156","DOI":"10.1136\/bmj.n156","article-title":"Effect of reductions in amyloid levels on cognitive change in randomized trials: Instrumental variable meta-analysis","volume":"372","author":"Ackley","year":"2021","journal-title":"BMJ"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Souchet, B., Micha\u00efl, A., Billoir, B., and Braudeau, J. (2023). Biological diagnosis of Alzheimer\u2019s Disease based on amyloid status: An. illustration of confirmation bias in medical research?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417544"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"e209884","DOI":"10.1212\/WNL.0000000000209884","article-title":"Challenges in a biological definition of Alzheimer disease","volume":"103","author":"Hazan","year":"2024","journal-title":"Neurology"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11910-007-0040-4","article-title":"Rethinking Alzheimer\u2019s disease: The role of age-related changes","volume":"7","author":"Drachman","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Pierce, A.L., and Kawas, C.H. (2017). Dementia in the oldest old: Beyond Alzheimer disease. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002263"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/bioe.12516","article-title":"On the reconceptualization of Alzheimer\u2019s disease","volume":"33","author":"Schermer","year":"2019","journal-title":"Bioethics"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.nbas.2021.100010","article-title":"Too narrow and too broad: Differentiating late-onset dementia from its historical entanglement with Alzheimer\u2019s disease","volume":"1","author":"Moseholm","year":"2021","journal-title":"Aging Brain"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13195-022-00971-3","article-title":"Considerations regarding a diagnosis of Alzheimer\u2019s disease before dementia: A systematic review","volume":"14","author":"Visser","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jamaneurol.2024.3766","article-title":"Alzheimer Disease-What\u2019s in a Name?","volume":"1","author":"Petersen","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuroscience.2014.09.061","article-title":"Neuroinflammation in Alzheimer\u2019s disease; A source of heterogeneity and target for personalized therapy","volume":"30","author":"Latta","year":"2015","journal-title":"Neuroscience"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1212\/WNL.0000000000007967","article-title":"Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic features","volume":"93","author":"Qiu","year":"2019","journal-title":"Neurology"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/WCO.0000000000000912","article-title":"What is \u2018Alzheimer\u2019s disease\u2019? The neuropathological heterogeneity of clinically defined Alzheimer\u2019s dementia","volume":"34","author":"Mehta","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13311-022-01185-z","article-title":"Heterogeneity in Alzheimer\u2019s disease diagnosis and progression rates: Implications for therapeutic trials","volume":"19","author":"Duara","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00702-021-02449-2","article-title":"Recent update on the heterogeneity of the Alzheimer\u2019s disease spectrum","volume":"129","author":"Jellinger","year":"2022","journal-title":"J. Neural Transm."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"e13122","DOI":"10.1111\/bpa.13122","article-title":"Hypothesis review: Alzheimer\u2019s overture guidelines","volume":"33","author":"Ferrer","year":"2023","journal-title":"Brain Pathol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/jep.12941","article-title":"Looking for trouble? Diagnostics expanding disease and producing patients","volume":"24","author":"Hofmann","year":"2018","journal-title":"J. Eval. Clin. Pract."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.2019.22373","article-title":"Potential consequences of changing disease classifications","volume":"323","author":"Doust","year":"2020","journal-title":"JAMA"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"c4670","DOI":"10.1136\/bmj.c4670","article-title":"What do we mean by Alzheimer\u2019s disease?","volume":"341","author":"Richards","year":"2010","journal-title":"BMJ"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mam.2015.06.001","article-title":"Politics of science: Progress toward prevention of the dementia\u2013Alzheimer\u2019s syndrome","volume":"43\u201344","author":"Khachaturian","year":"2015","journal-title":"Mol. Asp. Med."},{"key":"ref_231","first-page":"215","article-title":"Prospects for effective treatment of the Dementia-Alzheimer syndrome: A renewed Odyssey in search of the magic elixir","volume":"4","author":"Khachaturian","year":"2017","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jnnp.2011.241802","article-title":"Disease, diagnosis or syndrome?","volume":"11","author":"Pearce","year":"2011","journal-title":"Pract. Neurol."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Abbate, C. (2022). Research on Alzheimer\u2019s syndromes is critical to improve diagnosis, patient management and non-pharmacological treatments, but is under-pursued. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.1039899"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Dugger, B.N., and Dickson, D.W. (2017). Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol., 9.","DOI":"10.1101\/cshperspect.a028035"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2174\/1566524023666230907093451","article-title":"Neurodegenerative diseases: New hopes and perspectives","volume":"24","author":"Bhat","year":"2024","journal-title":"Curr. Mol. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"e70377","DOI":"10.1002\/alz.70377","article-title":"Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathways","volume":"21","author":"Bradley","year":"2025","journal-title":"Alzheimer\u2018s Dement."},{"key":"ref_237","first-page":"e2272","article-title":"Age-at-onset and APOE-related heterogeneity in pathologically confirmed sporadic Alzheimer disease","volume":"96","author":"Smirnov","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Gao, J., Bi, X., Jiang, W., and Wang, Y. (2025). Integration of multi-omics quantitative trait loci evidence reveals novel susceptibility genes for Alzheimer\u2019s disease. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-12290-2"},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Rajabli, F., Benchek, P., Tosto, G., Kushch, N., Sha, J., Bazemore, K., Zhu, C., Lee, W.P., Haut, J., and Hamilton-Nelson, K.L. (2025). Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer\u2019s disease. Genome Biol., 26.","DOI":"10.1186\/s13059-025-03564-z"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Nikolac Perkovic, M., Videtic Paska, A., Konjevod, M., Kouter, K., Svob Strac, D., Nedic Erjavec, G., and Pivac, N. (2021). Epigenetics of Alzheimer\u2019s disease. Biomolecules, 11.","DOI":"10.3390\/biom11020195"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1755-5949.2009.00117.x","article-title":"Friedland SP, Brayne C. Time for a change in the research paradigm for Alzheimer\u2019s disease: The value of a chaotic matrix modeling approach","volume":"16","author":"Hunter","year":"2010","journal-title":"CNS Neurosc. Ther."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jamiaopen\/ooy050","article-title":"The Alzheimer\u2019s comorbidity phenome: Mining from a large patient database and phenome-driven genetics prediction","volume":"2","author":"Zheng","year":"2019","journal-title":"JAMIA Open"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Morgan, S.L., Naderi, P., Koler, K., Pita-Juarez, Y., Prokopenko, D., Vlachos, I.S., Tanzi, R.E., Bertram, L., and Hide, W.A. (2022). Most pathways can be related to the pathogenesis of Alzheimer\u2019s disease. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.846902"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","article-title":"Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease","volume":"107","author":"Cotman","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41467-023-37304-3","article-title":"An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer\u2019s disease","volume":"14","author":"Lau","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.stem.2024.06.001","article-title":"Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration","volume":"31","author":"Saurat","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_247","first-page":"1432","article-title":"Vascular contributions to healthy aging and dementia","volume":"15","author":"Ge","year":"2024","journal-title":"Aging Dis."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.1227001","article-title":"Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals","volume":"337","author":"Ezzati","year":"2012","journal-title":"Science"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0022-510X(97)00289-X","article-title":"Treatable and reversible dementias: An update","volume":"153","author":"Piccini","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"ref_250","first-page":"495","article-title":"Alzheimer\u2019s disease prevention: A way forward","volume":"216","year":"2016","journal-title":"Rev. Clin. Esp."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.socscimed.2011.10.033","article-title":"Medical ideology as a double-edged sword: The politics of cure and care in the making of Alzheimer\u2019s disease","volume":"74","author":"Chaufan","year":"2012","journal-title":"Soc. Sci. Med."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Zimmerman, M. (2020). The Diseased Brain and the Failing Mind. Dementia in Science, Medicine and Literature of the Long Twentieth Century, Bloomsbury Academic.","DOI":"10.5040\/9781350121836"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/M17-3026","article-title":"Prevention of late-life dementia: No magic bullet","volume":"168","author":"Larson","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10072-019-3714-1","article-title":"Dementia: New vistas and opportunities","volume":"40","author":"Hachinski","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"e022846","DOI":"10.1136\/bmjopen-2018-022846","article-title":"Combining modifiable risk factors and risk of dementia: A systematic review and meta-analysis","volume":"9","author":"Peters","year":"2019","journal-title":"BMJ Open"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","article-title":"Evidence-based prevention of Alzheimer\u2019s disease: Systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","volume":"91","author":"Yu","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Weiss, J., Puterman, E., Prather, A.A., Ware, E.B., and Rehkopf, D.H. (2020). A data-driven prospective study of dementia among older adults in the United States. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239994"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"ref_259","unstructured":"Wilkinson, R., and Marmot, M. (2003). The Solid Facts, World Health Organization."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.31887\/DCNS.2019.21.1\/mbeeri","article-title":"Prevention of dementia presents a potentially critical platform for improvement of long-term public health","volume":"21","author":"Beeri","year":"2019","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_261","unstructured":"WHO Guidelines (2019). Risk Reduction of Cognitive Decline and Dementia, World Health Organization."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/S2666-7568(22)00028-9","article-title":"Ethics, evidence, and the environment in dementia risk reduction","volume":"3","author":"Daly","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Walsh, S., Govia, I., Peters, R., Richard, E., Stephan, B.C.M., Wilson, N.A., Wallace, L., Anstey, K.J., and Brayne, C. (2023). What would a population-level approach to dementia risk reduction look like, and how would it work?. Alzheimer\u2019s Dement.","DOI":"10.1002\/alz.12985"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/08959420.2023.2245672","article-title":"The potential of social policies in preventing dementia: An ecological study using systematic review and meta-analysis","volume":"36","author":"Bodryzlova","year":"2024","journal-title":"J. Aging Soc. Policy"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s40520-021-02045-0","article-title":"The health status: The ignored risk factor in dementia incidence. NEDICES cohort","volume":"34","author":"Contador","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"e13005","DOI":"10.1111\/eci.13005","article-title":"Alzheimer\u2019s disease: Only prevention makes sense","volume":"48","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1002\/alz.14108","article-title":"Considering challenges for the new Alzheimer\u2019s drugs: Clinical, population, and health system perspectives","volume":"20","author":"Walsh","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"101318","DOI":"10.1016\/j.arr.2021.101318","article-title":"Therapy for Alzheimer\u2019s disease: Missing targets and functional markers?","volume":"68","author":"Stoiljkovic","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.scib.2024.09.005","article-title":"The mechanisms, hallmarks, and therapies for brain aging and age-related dementia","volume":"69","author":"Jin","year":"2024","journal-title":"Sci. Bull."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"e70098","DOI":"10.1002\/trc2.70098","article-title":"Alzheimer\u2019s disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(25)01389-3","article-title":"Alzheimer\u2019s disease outlook: Controversies and future directions","volume":"406","author":"Frisoni","year":"2025","journal-title":"Lancet"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(19)30323-0","article-title":"Re-aligning scientific and lay narratives of Alzheimer\u2019s disease","volume":"18","author":"Frisoni","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","article-title":"Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease","volume":"18","author":"Inoue","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Yang, H.M. (2025). Vascular dementia: From pathophysiology to therapeutic frontiers. J. Clin. Med., 14.","DOI":"10.3390\/jcm14186611"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"e214113","DOI":"10.1212\/WNL.0000000000214113","article-title":"Multimarker Cerebral Small Vessel Disease Score and Risk of Incident Dementia in the Framingham Heart Study","volume":"105","author":"Pinheiro","year":"2025","journal-title":"Neurology"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/febs.16350","article-title":"Targeting cellular senescence with senotherapeutics: Senolytics and senomorphics","volume":"290","author":"Zhang","year":"2023","journal-title":"FEBS J."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"102141","DOI":"10.1016\/j.arr.2023.102141","article-title":"Cellular senescence in brain aging and neurodegeneration","volume":"93","author":"Eggen","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Puri, S., Shaheen, M., and Grover, B. (2023). Nutrition and cognitive health: A life course approach. Front. Public. Health, 11.","DOI":"10.3389\/fpubh.2023.1023907"},{"key":"ref_279","doi-asserted-by":"crossref","unstructured":"Twarowski, B., and Herbet, M. (2023). Inflammatory Processes in Alzheimer\u2019s Disease-pathomechanism, Diagnosis and treatment: A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076518"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer\u2019s disease: From immunotherapy to immunoprevention","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Feizpour, A., Doecke, J.D., Dor\u00e9, V., Krishnadas, N., Huang, K., Bourgeat, P., Laws, S.M., Fowler, C., Robertson, J., and Mackintosh, L. (2024). Detection and staging of Alzheimer\u2019s disease by plasma pTau217 on a high throughput immunoassay platform. EBioMedicine, 109.","DOI":"10.1016\/j.ebiom.2024.105405"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1038\/s41467-023-42596-6","article-title":"Plasma biomarkers predict Alzheimer\u2019s disease before clinical onset in Chinese cohorts","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Salvad\u00f3, G., Janelidze, S., Bali, D., Dolado, A.O., Therriault, J., Brum, W.S., Pichet Binette, A., Stomrud, E., Mattsson-Carlgren, N., and Palmqvist, S. (2025). Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease. JAMA Neurol.","DOI":"10.1001\/jamaneurol.2025.3217"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","article-title":"Plasma phospho-tau217 for Alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform","volume":"31","author":"Palmqvist","year":"2025","journal-title":"Nat. Med."},{"key":"ref_285","doi-asserted-by":"crossref","unstructured":"Monane, M., Maraganore, D.M., Carlile, R.M., Johnson, K.G., Merrill, D.A., Gitelman, D.R., Sharlin, K.S., VandeVrede, L.A., George, K.K., and Wang, J. (2025). Clinical utility of an Alzheimer\u2019s Disease blood test among cognitively impaired patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study. Diagnostics, 15.","DOI":"10.3390\/diagnostics15020167"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"e14536","DOI":"10.1002\/alz.14536","article-title":"Plasma p-tau217 and p-tau217\/A\u03b21-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer\u2019s disease: Insights for research and clinical practice","volume":"21","author":"Zhong","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00415-025-12996-3","article-title":"Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer\u2019s disease continuum. A systematic review and meta-analysis","volume":"272","author":"Antonioni","year":"2025","journal-title":"J. Neurol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"100252","DOI":"10.1016\/j.tjpad.2025.100252","article-title":"Plasma p-tau217 predicting brain-wide tau accumulation in preclinical, AD","volume":"12","author":"Moon","year":"2025","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","article-title":"The characterisation of subjective cognitive decline","volume":"19","author":"Jessen","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_290","first-page":"e70116","article-title":"The two cut-offs approach for plasma p-tau217 in detecting Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment","volume":"17","author":"Giacomucci","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"fcad057","DOI":"10.1093\/braincomms\/fcad057","article-title":"Plasma phosphorylated tau 217 in preclinical Alzheimer\u2019s disease","volume":"5","author":"Jonaitis","year":"2023","journal-title":"Brain Commun."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"020310","DOI":"10.7189\/jogh.09.020310","article-title":"Globalising strategies to meet global challenges: The case of ageing and dementia","volume":"9","author":"Parra","year":"2019","journal-title":"J. Glob. Health"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/21\/7752\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:50:12Z","timestamp":1762199412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/21\/7752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":293,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcm14217752"],"URL":"https:\/\/doi.org\/10.3390\/jcm14217752","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}